Treatment of Mastoid Effusions in Pediatric Patients
For pediatric patients with mastoid effusions (otitis media with effusion extending into mastoid air cells), initial management should consist of watchful waiting for 3 months, as the condition typically resolves spontaneously without intervention. 1
Initial Management Strategy
The presence of fluid in the mastoid air cells is a common extension of middle ear effusion and does not automatically require aggressive intervention. 2 The key is distinguishing between:
- Simple mastoid effusion (fluid in mastoid cells accompanying OME) - managed conservatively
- Acute mastoiditis (suppurative infection with systemic symptoms) - requires urgent treatment 3
Watchful Waiting Protocol
- Manage with observation for 3 months from diagnosis if the child is not at-risk and has no concerning symptoms 1
- During this period, avoid antibiotics, steroids (intranasal or systemic), antihistamines, or decongestants as these provide no benefit for OME 1
- Most mastoid effusions will clear spontaneously as the middle ear effusion resolves 2
Assessment of At-Risk Status
Evaluate whether the child has risk factors that would warrant earlier intervention: 1
- Permanent hearing loss independent of OME
- Suspected or confirmed speech/language delay
- Autism spectrum disorder or other developmental disorders
- Syndromes (e.g., Down syndrome) or craniofacial disorders affecting Eustachian tube function
- Cleft palate
- Blindness or uncorrectable visual impairment
- Cognitive, speech, or language delays
For at-risk children, obtain hearing testing immediately rather than waiting 3 months 1
Hearing Assessment and Follow-Up
- Obtain age-appropriate hearing test if OME (and associated mastoid effusion) persists ≥3 months 1
- Reevaluate at 3-6 month intervals until effusion resolves, significant hearing loss is identified, or structural abnormalities develop 1
- Average hearing loss with middle ear effusion is 25 decibels, which can impact speech and language development 1
Surgical Intervention Criteria
Surgery becomes indicated when: 1
- OME persists ≥4 months with documented hearing loss or other symptoms
- The child is at-risk (see above) with persistent OME regardless of duration
- Structural damage to tympanic membrane or middle ear develops
Surgical Approach
For children <4 years old: 1
- Tympanostomy tubes are the sole recommended procedure
- Adenoidectomy should NOT be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis) separate from the OME
For children ≥4 years old: 1
- Tympanostomy tubes, adenoidectomy, or both may be performed
- Adenoidectomy provides 50% reduction in need for future operations if repeat surgery is required 1
In most cases, insertion of ventilating tubes through the tympanic membrane provides adequate aeration of both the middle ear and mastoid air cell system, allowing the mucosa to return to normal 2
Critical Distinction: When to Suspect Acute Mastoiditis
Immediately escalate care if the patient develops: 3, 4
- Postauricular erythema, swelling, or tenderness
- Protrusion of the auricle
- Fever with systemic symptoms
- Failure to improve after 48 hours of appropriate antibiotic therapy for acute otitis media
- Severe ear pain
These findings suggest acute mastoiditis rather than simple mastoid effusion and require:
- Immediate IV broad-spectrum antibiotics (ampicillin-sulbactam or ceftriaxone) 3, 4
- Otolaryngology consultation 3
- CT temporal bone with IV contrast if no improvement after 48 hours or clinical deterioration 3
- Possible myringotomy or mastoidectomy 3
Common Pitfalls to Avoid
- Do not treat simple mastoid effusion with antibiotics - they are ineffective for OME and contribute to resistance 1
- Do not confuse mastoid effusion (benign, self-limited) with acute mastoiditis (suppurative infection requiring urgent treatment) 3, 4
- Do not perform routine screening CT scans - imaging is only indicated if acute mastoiditis is suspected or the child fails conservative management 3
- Do not rush to surgery - 60-70% of children still have middle ear effusion at 2 weeks post-treatment, decreasing to 10-25% at 3 months, which is expected and does not require intervention 3